Global University Venturing

Bio-Techne has bought University of Minnesota-founded genome editing platform operator B-Mogen Biotechnologies to solidify a business relationship that dates to 2016.

Deerfield Management and Columbia University have launched a $130m commercialisation fund, Hudson Heights Innovation, to support the university's early-stage biomedical research.

OncoMyx Therapeutics was co-founded by ASU's Grant McFadden and will use the series A funding to advance the development of its lead asset aimed at several indications of cancer.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

UT Health's pulmonary drug treatment spinout Lung Therapeutics has raised a $36m series C, adding to at least $55m in previous funding from backers including UT Horizon Fund.

University of Colorado Hospital-affiliated UC Health and University of Virginia LVG Venture Fund both featured in a series A round for healthcare analytics platform creator RxRevu.

Sally-Ann Williams will leave Google to take the reins at Cicada Innovations, the deeptech accelerator backed by four Australian universities.

IP Group has backed Azuri Technologies, which markets pay-as-you-go solar-powered appliances to households in sub-Saharan Africa.

The anti-fraud technology provider, co-founded by CAE faculty, has received $50.7m in a round led by VMS Investment Group that was also backed by existing investor Legend Capital.

The capital will let RSVP.ai continue the commercialisation of natural language processing technologies derived from the work of its founding partners Waterloo and Tsinghua universities.

Spun out of ETH Zurich, the logistics technology developer has secured $35.2m from DiaMedCare to roll out its upgraded supply chain-monitoring sensors.